Journal of Foot and Ankle Surgery (Asia Pacific)

Register      Login

VOLUME 6 , ISSUE 1 ( January-June, 2019 ) > List of Articles

Original Article

Efficacy of Platelet-rich Plasma vs Corticosteroid Injection in Chronic Plantar Fasciitis: A Comparative Study

Manjeet Singh, Ashwani Ummat, Chetan Sharma, Praveen S Thivari, Sonia Kochhar

Keywords : Chronic plantar fasciitis, Corticosteroid, Platelet-rich plasma

Citation Information : Singh M, Ummat A, Sharma C, Thivari PS, Kochhar S. Efficacy of Platelet-rich Plasma vs Corticosteroid Injection in Chronic Plantar Fasciitis: A Comparative Study. J Foot Ankle Surg Asia-Pacific 2019; 6 (1):2-6.

DOI: 10.5005/jp-journals-10040-1097

License: CC BY-NC 4.0

Published Online: 01-06-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Chronic plantar fasciitis (PF) is the most common cause of foot complaints making up to 11–15% of the foot symptoms requiring professional care among adults. Also, it is a common problem that affects sport participants as well as inactive middle-aged individuals. The purpose of this study was to compare the effect of steroid and platelet-rich plasma (PRP) in chronic PF. The results were assessed by comparing American orthopedic foot and ankle scale (AOFAS) and visual analogue scale (VAS) before injection, 1, 2, and 6 months after injection in both groups comprising 25 patients in each group. Results: In our study of 50 patients, in steroid group-A, there is significant change in mean VAS from 6.28 ± 0.86 before follow-up injection to 2.8 ± 0.76 in first follow-up visit (1 month after injection) and to 2.92 ± 0.75 in second follow-up visit (2 months after 1st injection) and remained constant at 2.92 + 0.75 at third follow-up (6 months post 1st injection) and significant change in mean AOFAS from 67 ± 10 before injection to 85.76 ± 5.44 in first follow-up visit (1 month after injection) and to 84.16 + 5.94 in second follow-up visit (2 months after first injection) and deteriorated further to 83.92 + 5.84 at third follow-up (6 months after first injection). In 25 patients in group B, there is significant change in mean VAS from 5.8 ± 80.78 before follow-up injection to 1.96 ± 0.45 in first follow-up visit (1 month after injection) and to 1.96 ± 0.45 in second follow-up visit (2 months after first injection) and remained constant at 1.96 ± 0.45 at third follow-up (6 months post first injection) and significant change in AOFAS from 68.44 ± 17.78 before injection to 89.56 ± 0.91 in first follow-up visit (1 month after injection) and to 89.84 ± 0.55 in second follow-up visit (2 months after first injection) and improved further to 89.92 ± 0.40 at third follow-up (6 months after first injection). Conclusion: PRP injection is more effective than corticosteroid injection in the treatment of chronic PF in the long run.


PDF Share
  1. Singh D, Angel J, et al. Fortnightly review. Plantar fasciitis. BMJ 1997 Jul 19;315(7101):172–175. DOI: 10.1136/bmj.315.7101.172.
  2. Bolgla LA, Malone TR. Plantar fasciitis and the windlass mechanism: a biomechanical link to clinical practice. J Athl Train 2004 Jan;39(1): 77–82.
  3. Barrett SJ, O'Malley R. Plantar fasciitis and other causes of heel pain. Am Fam Phys 1999 Apr 15;59(8):2200–2206.
  4. Tahririan MA, Motififard M, et al. Plantar fasciitis. J Res Med Sci 2012 Aug;17(8):799–804.
  5. Lapidus PW, Guidotti FP. Local injections of hydrocortisone in 495 orthopedic patients. Ind Med Surg 1957 May;26(5):234–244.
  6. Yang W, Han Y, et al. Platelet-rich plasma as a treatment for plantar fasciitis. Medicine (Baltimore) 2017 Nov;96(44):e8475. DOI: 10.1097/MD.0000000000008475.
  7. Dhillon RS, Schwarz EM, et al. Platelet-rich plasma therapy—future or trend? Arthritis Res Ther 2012 Aug 8;14(4):219. DOI: 10.1186/ar3914.
  8. Cole BJ, Seroyer ST, et al. Platelet-Rich Plasma: Where Are We Now and Where Are We Going? Sport Heal A Multidiscip Approach 2010 May 29;2(3):203–210. DOI: 10.1177/1941738110366385.
  9. Shetty VD, Dhillon M, et al. A study to compare the efficacy of corticosteroid therapy with platelet-rich plasma therapy in recalcitrant plantar fasciitis: a preliminary report. Foot Ankle Surg 2014. DOI: 10.1016/j.fas.2013.08.002.
  10. Monto RR. Platelet-Rich Plasma Efficacy vs Corticosteroid Injection Treatment for Chronic Severe Plantar Fasciitis. Foot Ankle Int 2014 Apr 13;35(4):313–318. DOI: 10.1177/1071100713519778.
  11. Kumar V, Millar T, et al. The treatment of intractable plantar fasciitis with platelet-rich plasma injection. Foot 2013 Jun;23(2–3):74–77. DOI: 10.1016/j.foot.2013.06.002.
  12. Akşahin E, Doğruyol D, et al. The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg 2012 Jun 8;132(6):781–785. DOI: 10.1007/s00402-012-1488-5.
  13. Ragab EMS, Othman AMA. Platelets rich plasma for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg 2012 Aug 4;132(8):1065–1070. DOI: 10.1007/s00402-012-1505-8.
  14. Stephen LB, Susan EE. Growth Factors for Chronic Plantar Fasciitis? Podiatry Today 2004;17(11):36–42.
  15. Omar AS, Ibrahim ME, et al. Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: randomized clinical trial. Egypt Rheumatol 2012 Apr 1;34(2):43–49. DOI: 10.1016/j.ejr.2011.12.001.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.